Diabetes, fracture, and bone fragility

被引：16

作者：

Schwartz A.V. ^{[1
]}

Sellmeyer D.E. ^{[1
]}

机构：

[1] Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94107

来源：

Current Osteoporosis Reports | 2007年 / 5卷 / 3期

关键词：

Bone Mineral Density; Vertebral Fracture; Fracture Risk; Raloxifene; Increase Fracture Risk;

D O I：

10.1007/s11914-007-0025-x

中图分类号：

学科分类号：

摘要：

Recent studies have added to the evidence that type 1 and type 2 diabetes are associated with increased risk of hip fracture and other fractures. More frequent falls probably account for some of this increased risk, but reduced bone strength may also play a role. Although type 1 diabetes is associated with lower bone density, those with type 2 diabetes usually have elevated bone density. Yet for both types of diabetes, bone appears to be more fragile for a given density. Diabetes can affect bone through multiple pathways - some with contradictory effects - including obesity, insulin levels, hyperglycemia, and advanced glycation end products in collagen. Treatment with thiazolidinediones may increase fracture risk, at least in older women. Clinicians need to be aware of the increased fracture risk associated with diabetes. Additional research is needed to clarify the mechanisms underlying this increased risk and the best approaches to fracture prevention. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：105 / 111

页数：6

共 52 条

[1]

Ahmed L.A., Joakimsen R.M., Berntsen G.K., Et al., Diabetes mellitus and the risk of non-vertebral fractures: The Tromso study, Osteoporos Int, 17, pp. 495-500, (2006)

[2]

Vestergaard P., Rejnmark L., Mosekilde L., Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk, Diabetologia, 48, pp. 1292-1299, (2005)

[3]

Schwartz A.V., Sellmeyer D.E., Women, type 2 diabetes, and fracture risk, Curr Diab Rep, 4, pp. 364-369, (2004)

[4]

Holmberg A.H., Johnell O., Nilsson P.M., Et al., Risk factors for hip fractures in a middle-aged population: A study of 33,000 men and women, Osteoporos Int, 16, pp. 2185-2194, (2005)

[5]

Bonds D.E., Larson J.C., Schwartz A.V., Et al., Risk of fracture among women with type 2 diabetes: The Women's Health Initiative observational study, J Clin Endocrinol Metab, 91, pp. 3404-3410, (2006)

[6]

Janghorbani M., Feskanich D., Willett W.C., Hu F., Prospective study of diabetes and risk of hip fracture: The Nurses' Health Study, Diabetes Care, 29, pp. 1573-1578, (2006)

[7]

Lipscombe L.L., Jamal S.A., Booth G.L., Hawker G.A., The risk of hip fractures in older individuals with diabetes: A population-based study, Diabetes Care, 30, pp. 835-841, (2007)

[8]

Dobnig H., Piswanger-Solkner J.C., Roth M., Et al., Type 2 diabetes mellitus in nursing home patients: Effects on bone turnover, bone mass, and fracture risk, J Clin Endocrinol Metab, 91, pp. 3355-3363, (2006)

[9]

Holmberg A.H., Johnell O., Nilsson P.M., Et al., Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women, Osteoporos Int, 17, pp. 1065-1077, (2006)

[10]

Nicodemus K.K., Folsom A.R., Iowa Women's Health Study: Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women, Diabetes Care, 24, pp. 1192-1197, (2001)

← 1 2 3 4 5 6 →